What does the £900M NHS AI framework mean for UK healthcare? Nelson Advisors interviewed by Healthcare Business International
NA
Nelson Advisors interviewed by Healthcare Business International for their 'What does the £900M NHS AI framework mean for UK healthcare?' story
Nelson Advisors partner Lloyd Price was interviewed by Healthcare Business International for their 'What does the £900M NHS AI framework mean for UK healthcare?' story.
What it means for investors
For investors and suppliers, the framework is widely seen as a significant market signal, raising both the bar for entry and the visibility of NHS demand for AI.
“The framework centralises procurement, raising the bar for regulatory approvals and data requirements,” Lloyd Price, partner at M&A advisory firm Nelson Advisors, a Boutique Investment Bank focused exclusively on the healthtech and medtech sectors, told HBI.
“For investors, this creates clearer visibility on emerging winners, those that secure framework access and start winning bids are likely to accelerate growth rapidly and compound advantage,” he added.
Price also highlighted that the framework could improve supplier economics over time byreducing reliance on long and costly enterprise sales cycles. “For private equity, that’svery attractive,” he said.
Meanwhile, Price noted that existing supplier contracts in hospitals could slow near term disruption.
“Even if you get onto the framework, hospitals may already have long-term contracts in place with incumbents like Siemens or Philips. So access is not immediate.”
Market structure and long-term outlook
Despite these challenges, the framework marks a structural shift in the NHS AI market.
Price added that the most immediate demand will likely be concentrated in imaging, diagnostics, administrative automation and workforce optimisation.
Nelson Advisors > European MedTech and HealthTech Investment Banking
Nelson Advisors specialise in Mergers and Acquisitions, Partnerships and Investments for Digital Health, HealthTech, Health IT, Consumer HealthTech, Healthcare Cybersecurity, Healthcare AI companies. www.nelsonadvisors.co.uk
Nelson Advisors regularly publish Thought Leadership articles covering market insights, trends, analysis & predictions @ https://www.healthcare.digital
Nelson Advisors publish Europe’s leading HealthTech and MedTech M&A Newsletter every week, subscribe today! https://lnkd.in/e5hTp_xb
Nelson Advisors pride ourselves on our DNA as ‘Founders advising Founders.’ We partner with entrepreneurs, boards and investors to maximise shareholder value and investment returns. www.nelsonadvisors.co.uk
#NelsonAdvisors #HealthTech #DigitalHealth #HealthIT #Cybersecurity #HealthcareAI #ConsumerHealthTech #Mergers #Acquisitions #Partnerships #Growth #Strategy #NHS #UK #Europe #USA #VentureCapital #PrivateEquity #Founders #SeriesA #SeriesB #Founders #SellSide #TechAssets #Fundraising #BuildBuyPartner #GoToMarket #PharmaTech #BioTech #Genomics #MedTech
Nelson Advisors LLP
Hale House, 76-78 Portland Place, Marylebone, London, W1B 1NT
Meet Nelson Advisors @ 2026 Events
Digital Health Rewired > March 2026 > Birmingham, UK
NHS ConfedExpo > June 2026 > Manchester, UK
HLTH Europe > June 2026, Amsterdam, Netherlands
HIMSS AI in Healthcare > July 2026, New York, USA
Bits & Pretzels > September 2026, Munich, Germany
World Health Summit 2026 > October 2026, Berlin, Germany
HealthInvestor Healthcare Summit > October 2026, London, UK
HLTH USA 2026 > October 2026, USA
Barclays Health Elevate > October 2026, London, UK
Web Summit 2026 > November 2026, Lisbon, Portugal
MEDICA 2026 > November 2026, Düsseldorf, Germany
Venture Capital World Summit > December 2026 Toronto, Canada